Incyte
INCY
$0.04 (0.06%)
1D
1W
3M
1Y
5Y
ALL
Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company also conducts commercial and clinical development Read More...Read Less
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 1 day ago • INCY
Incyte Stock Rises on QIAGEN Deal to Advance Blood Cancer DiagnosticsBusiness Wire • 3 days ago • INCY
QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)Business Wire • 3 days ago • INCY
Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA2025Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.